EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis

Xueli Zhao, Yuze Qin, Bowen Li, Yue Wang, Jiao Liu, Bo Wang, Jia Zhao, Jiaqi Yin, Lanlan Zhang, Jing Li, Junzhe Huang, Kun Chen und 2 weitere

Journal of Nanobiotechnology · 2025

DOI: 10.1186/s12951-024-03083-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nanobiotechnology, 2025. Verfasst von Xueli Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Shaanxi Provincial Key Laboratory of Clinical Genetics, School of Basic Medicine, Fourth Military M…. Hauptthemen laut MEDLINE: Fibrosis, Cerium, Adenosine Triphosphate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Xijing Hospital Medical Personnel Training Propel Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac fibrosis plays a critical role in the progression of various forms of heart disease, significantly increasing the risk of sudden cardiac death. However, currently, there are no therapeutic strategies available to prevent the onset of cardiac fibrosis. METHODS AND RESULTS: Here, biomimetic ATP-responsive nanozymes based on genetically engineered cell membranes are adapted to specifically recognize activated cardiac fibroblasts (CFs) for the treatment of cardiac fibrosis. By fusing the anti-FAP CAR genetically engineered cell membrane to zeolitic imidazole frameworks-90 (zif-90) cores loaded with antioxidant nanozymes CeO2 and siCTGF (siRNA targeting CTGF), these nanoparticles, called FM@zif-90/Ce/siR NPs, are demonstrated to effectively reduce the accumulation of myofibroblasts and the formation of fibrotic tissue, while restoring cardiac function. CONCLUSIONS: These findings demonstrate that the combination of CeO2 and siCTGF has a beneficial curative effect on cardiac fibrosis, with significant translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisCeriumAdenosine TriphosphateAnimalsGenetic EngineeringNanoparticlesFibroblastsMyocardiumBiomimetic MaterialsMaleBiomimeticsMiceRNA, Small InterferingHumansRatsMyofibroblastsConnective Tissue Growth Factor

Stichwörter der Autor:innen

ATP-responsiveCardiac fibrosisGenetically engineeredNanozymeZeolitic imidazole frameworks-90

Substanzen

CeriumAdenosine Triphosphateceric oxideRNA, Small InterferingConnective Tissue Growth Factor

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Shaanxi Provincial Key Laboratory of Clinical Genetics, School of Basic Medicine, Fourth Military Medical University, Xi'an, 710032, China.
  • Department of Ultrasound, Xijing Hypertrophic Cardiomyopathy Center, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
  • Department of Anatomy, Histology and Embryology and K.K. Leung Brain Research Centre, School of Basic Medicine, Fourth Military Medical University, Xi'an, 710032, China. chenkun@fmmu.edu.cn.
  • Department of Ultrasound, Xijing Hypertrophic Cardiomyopathy Center, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. liuliwen@fmmu.edu.cn.
  • Department of Laboratory, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China. wuym@fmmu.edu.cn.
  • Department of Biochemistry and Molecular Biology, Shaanxi Provincial Key Laboratory of Clinical Genetics, School of Basic Medicine, Fourth Military Medical University, Xi'an, 710032, China. wuym@fmmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Xijing Hospital Medical Personnel Training Propel Project

Zitieren

APA

Zhao, X., Qin, Y., Li, B., Wang, Y., Liu, J., Wang, B., Zhao, J., Yin, J., Zhang, L., Li, J., Huang, J., Chen, K., Liu, L., & Wu, Y. (2025). Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-024-03083-2

Vancouver

Zhao X, Qin Y, Li B, Wang Y, Liu J, Wang B, et al. Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis. Journal of Nanobiotechnology. 2025. doi:10.1186/s12951-024-03083-2

BibTeX
@article{Zhao2025,
  author = {Zhao, Xueli and Qin, Yuze and Li, Bowen and Wang, Yue and Liu, Jiao and Wang, Bo and Zhao, Jia and Yin, Jiaqi and Zhang, Lanlan and Li, Jing and Huang, Junzhe and Chen, Kun and Liu, Liwen and Wu, Yuanming},
  title = {Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis},
  journal = {Journal of Nanobiotechnology},
  year = {2025},
  doi = {10.1186/s12951-024-03083-2}
}
Kostenlos starten →